Ads
related to: acute myeloid leukemia- Dosing & Monitoring
Twice Daily
Oral Dosing.
- Safety
Learn More About Well Characterized
Safety Profile.
- Mechanism of Action
Inhibits Mutant IDHI and
Restores Myeloblast Differentiation
- Access & Resources
Support is Available for
You and Your Patients.
- Dosing & Monitoring
Search results
Moleculin Abstract Accepted for Poster Presentation at the European Hematology Association (EHA)...
WTRF Wheeling· 6 days agoMoleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses ...
MD Anderson Research Highlights for May 21, 2024 | Newswise
Newswise· 1 day agoThe University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These
Local Leukemia & Lymphoma Society holds annual fundraiser for blood cancer research
Local 12 Cincinnati· 6 days agoThe local chapter of the Leukemia and Lymphoma Society held its annual fundraiser to raise money for...
Q1 2024 Exscientia PLC Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 13 hours agoToday, we are providing updates for our highly differentiated LSD1 inhibitor the XS74539, or 539, which continues its progression towards a Phase 1 clinical trial in acute ...
Syrian first lady Asma al-Assad diagnosed with leukemia, president's office says
AOL· 1 day agoThe first lady of Syria, Asma al-Assad, has been diagnosed with leukemia, according to the nation's top officials. Asma al-Assad, wife of Syrian President Bashar al-Assad, has been forced to ...
Aileron Therapeutics (NASDAQ:ALRN) Announces Earnings Results, Misses Estimates By $0.72 EPS
ETF DAILY NEWS· 9 hours agoAileron Therapeutics (NASDAQ:ALRN – Get Free Report) announced its quarterly earnings data on Monday. The company reported ($0.86) EPS for the quarter, missing the consensus estimate of ($0.14 ...
Earnings call: Bio-Path Holdings reports promising Q1 2024 results By Investing.com
Investing.com· 7 days agoBio-Path Holdings (NASDAQ: NASDAQ:BPTH), a biotechnology company focused on developing therapeutic...
Newswise Expert | Namrata Chandhok, University of Miami Health System, Miller School of Medicine
Newswise· 2 days agoNamrata Chandhok, M.D. is an Assistant Professor of Clinical Medicine (Hematology) at the University of Miami Miller School of Medicine/ Sylvester Comprehensive Cancer Center. Dr. Chandhok specializes ...
Nicklaus Children’s and FIU Collaborate on Groundbreaking Cancer Research That is Saving Lives
Miami Herald via Yahoo News· 3 days agoDiscover how Nicklaus Children’s Hospital is leading the way in pediatric brain cancer care,...
Anti-diabetic treatment associated with reduced risk of developing blood cancer
Medical Xpress· 5 days agoMetformin is a therapy used to treat high blood sugar in people with type 2 diabetes that increases...